Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by argentia77on Nov 18, 2015 9:58am
72 Views
Post# 24300357

RE:Beacon Securities - recent note to clients

RE:Beacon Securities - recent note to clientsLast sentence in the note from Beacon: "No mention of ridiculously low trading volumes, I wonder what he is promoting these days?" 

Did wnotwrong get a job writing notes for Beacon?


"No mention of ridiculously low trading volumes, I wonder what he is promoting these days?" 
sunshine7 wrote: The re-valuing of the sector, coupled with Concordias substantial debt load, probably means the end of its financial arbitrage as a means to continue its non-organic [growth] for the foreseeable future Doug Cooper, an analyst with Beacon Securities... This [heavy debt load] has forced the company to change its strategy from a growth-through-acquisition story to purely an internal growth story, driven by the new product launches at AMCo. ... With no imminent acquisition catalysts, we believe the shares will be range bound. .... the old story repeats itself - CXR has acquires products not companies. Amco was an exception and along with it came operational synergies and 60 product pipeline. No mention of enough cash flow to put a serious dent in the debt in short order or forecast growth in sales. No mention of ridiculously low trading multiples. I wonder what he is promoting these days?


<< Previous
Bullboard Posts
Next >>